28 janvier 2017 - Emeran ATANGANA ETEME

Cameroon: DECISION No.0606/DIMINSANTE/CAB OF 29 JUNE 2010 TO FIX PRICES IN THE SUB PRIVATE SECTOR OF THE DIFFERENT SUBSIDISED FIXED-DOSE COMBINATIONS OF ARTERSUNATE/AMODIAQUINE USED IN THE MANAGEMENT OF UNCOMPLICATED MALARIA.

DECISION No.0606/DIMINSANTE/CAB OF 29 JUNE 2010 TO FIX PRICES IN THE SUB PRIVATE SECTOR OF THE DIFFERENT SUBSIDISED FIXED-DOSE COMBINATIONS OF ARTERSUNATE/AMODIAQUINE USED IN THE MANAGEMENT OF UNCOMPLICATED MALARIA.

 

 

THE MINISTER OF PUBLIC HEALTH,

 

 

 

Mindful of the Constitution,

 

Mindful of Law No.96/03 of 04 January 1996 on the Framework Law in the health domain,

 

Mindful of Law No. 090/062 of December 1990 to grant special dispensation to public health facilities concerning finance;

 

Mindful of Decree No.93/228/PM of 15 March 1993 to set the implementation conditions of Law No.90/062 of 19 December 1990, to grant special dispensation to Health facilities concerning finance;

 

Mindful of Decree No.2002/209 of 19 August 2004 to organize the Ministry of Public Health;

 

Mindful of Decree No.2004/320 of 8 December 2004 to organize the Government;

 

Mindful of Decree No.2004/322 of 8 December 2004 to form the Government as amended Decree No.2009/223 of 30 June 2009 to reshuffle the Government;

 

Mindful of Decree No.2009/222 of 30 June 2009 to appoint a Prime Minister, Head of Government;

 

Mindful of Decree No.2005/252 30 June 2005 to create, organise and regulate the functioning of the National Essential Drugs Procurement Centre;

 

Mindful of Decision No.0092/D/MSP/CAB of 29 November 2001, to fix the prices of drugs and essential medical supplies at the level of Regional Pharmaceutical Procurement Centre sans health facilities;

 

Considering the need for services;

 

HEREBY DECIDES AS FOLLOWS:

 

 

1 – This Decision sets in the pharmaceutical sub private sector, the prices of subsidized fixed-dose combinations of Artesunate-Amodiaquine used in the management of non complicated malaria.

 

  1. - As from the signing date of this decision, the prices applicable to subsidized fixed-dose combinations of Artesunate-Amodiaquine used orally in the treatment of non complicated malaria are set in the private pharmaceutical sector as follows:

 

 

  1. Sub private non profit making pharmaceutical sector

 

ITEM   CENAME PRIVATE WHOLESALERS DRUGS STORE
    CFAF  FCFA
  • -
Artesunate – Amodiaquine 25 mg/67.5 mg
  • Set
Blister of 3 tablets 49 61 100
  • -
Artesunate – Amodiaquine 50 mg/270 mg
Blister of of 3 tablets comprimes 61 76 125
  • -
Artesunate – Amodiaquine 100 mg/67.5 mg
Blister of 3 tablets 88 110 175
  • -
Artesunate – Amodiaquine 100 mg/67.5 mg
Blister of 6 tablets 137 170 275

 

 

 

 

 

 

 

ITEM   CENAME OFFICIAL PRICES IN THE SUB PRIVATE NON PROFIT-MAKING SECTOR  
    CFAF  
Artesunate-Amodiaquine 25 mg/67.5 mg 49 75
Blister of 3 tablets
Artesunate-Amodiaquine 50 mg/135 mg 61 95
Blister of 3 tablets
Artesunate-Amodiaquine 100 mg/270 mg 88 135
Blister of 3 tablets
Artesunate-Amodiaquine 100 mg/270 mg 137 210
Blister of 6 tablets

 

  1. - The prices fixed can be reviewed by Act of the Minister of Public Health following economic and social circumstances.

 

  1. - Consultation cost for patients shall be posted publicly in drug stores and health facilities.

 

  1. - This decision repeals all previous repugnant provisions.

 

 

  1. - The Inspector General of Pharmaceutical Services, the General Manager of CENAME, the Director of Pharmacy and Drugs, the Director of Disease Control, the Director of the organization of care and health Technology, Pharmacists in charge of wholesale establishments, and drug stores are in charge each in their capacity for the strict implementation of this decision.

 

  1. - This decision shall be registered and published in English and French wherever necessary.

 


                                                                    André Mama Fouda

                                                                      MINISTER OF PUBLIC HEALTH

Les instructments publiques

Laisser un commentaire

Votre adresse de messagerie ne sera pas publiée. Les champs obligatoires sont indiqués avec *

Vous pouvez utiliser ces balises et attributs HTML : <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>